A Study of LY3200882 in Participants With Solid Tumors
Clinical trial NCT02937272 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02937272
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2020-02-27
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.